Merz – SAFE Post-Stroke Spasticity Project

 “Spasticity is one of the most debilitating effects of stroke. It is a real medical condition and stroke survivors should speak to their GP, or stroke specialist, about getting the support they need.”

Dr Madina Kara, neuroscientist at the Stroke Association

The Merz/SAFE post-stroke spasticity project aims to create an educational space in order to raise awareness of the treatment options available to stroke survivors experiencing post-stroke spasticity. We want to ensure that stroke survivors and their carers receive accurate and accessible information about the treatment options available to them.

We believe that everyone who has had a stroke should have the opportunity to make the best possible recovery. It is estimated that up to a third of stroke survivors experience spasticity, however rehabilitation is only given to a small percentage of people who could benefit. Spasticity affects up to a third of stroke survivors and can leave those with the condition dependent on others to carry out the most basic, everyday tasks, such as getting dressed and eating. Studies have shown that around 70% of stroke survivors living with spasticity say it has a major impact on their life.

About SAFE and Merz

Stroke Alliance for Europe (SAFE) is a coalition of 30 non-governmental organisations, including the Stroke Association, leading the fight against stroke for over 14 years. Merz is a privately held pharmaceutical company based in Frankfurt, Germany with affiliates across Europe, as well as the US, Canada, Mexico, Brazil and Asia Pacific. Merz is active in research, development and distribution of innovative products in the areas of aesthetic medicine and neurologically induced movement disorders.

The project’s web site is

Please find the updates on this project here.

safe merz